Schechter Investment Advisors LLC Buys Shares of 963 Humana Inc. (NYSE:HUM)

Schechter Investment Advisors LLC purchased a new position in shares of Humana Inc. (NYSE:HUM) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 963 shares of the insurance provider’s stock, valued at approximately $244,000.

A number of other large investors have also modified their holdings of HUM. FPC Investment Advisory Inc. purchased a new stake in Humana in the fourth quarter valued at approximately $27,000. Centricity Wealth Management LLC acquired a new position in shares of Humana during the 4th quarter worth approximately $30,000. Ashton Thomas Securities LLC acquired a new position in Humana in the 3rd quarter valued at $31,000. Atwood & Palmer Inc. raised its stake in Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 60 shares during the last quarter. Finally, Kestra Investment Management LLC acquired a new position in Humana in the 4th quarter valued at $49,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Shares of NYSE:HUM opened at $265.59 on Friday. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The business has a 50-day moving average of $271.72 and a two-hundred day moving average of $284.78. The stock has a market capitalization of $32.04 billion, a P/E ratio of 26.69, a P/E/G ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last announced its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.33%. Humana’s payout ratio is presently 35.58%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on HUM. Barclays upped their target price on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Truist Financial increased their price target on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research report on Monday, January 6th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $283.00 price target on shares of Humana in a research report on Wednesday, February 12th. Morgan Stanley cut their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $290.00 price target on shares of Humana in a research note on Wednesday, February 12th. Twenty analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $285.68.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.32% of the stock is currently owned by corporate insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.